Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2009

01-07-2009 | Review

Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part II

Authors: Sharad Sharma, Ahmet Gurakar, Cemalettin Camci, Nicolas Jabbour

Published in: Digestive Diseases and Sciences | Issue 7/2009

Login to get access

Abstract

Over the last decade the number of patients undergoing transplantation has increased. At the same time, effective peri- and postoperative care and better surgical techniques have resulted in greater numbers of recipients achieving long-term survival. Identification and effective management in the form of adequate treatment is essential, since any delay in diagnosis or treatment may result in graft loss or serious threat to patient’s life. Various aspects of endoscopic findings that can be commonly encountered among liver transplant recipients are discussed herein. Topics include: persistent and/or recurrent esophageal varices, reflux, Candida or cytomegalovirus (CMV) esophagitis, esophageal neoplasms, posttransplant peptic ulcer, biliary complications, posttransplant lymphoproliferative disorder (PTLD), Kaposi’s sarcoma, CMV colitis and inflammatory bowel disease, colonic neoplasms, Clostridium difficile infection, and graft versus host disease (GVHD).
Literature
2.
go back to reference Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355–360.PubMedCrossRef Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355–360.PubMedCrossRef
8.
go back to reference Gertsch P, Stipa F, Ho J, Yuen ST, Luk I, Lauder IJ. Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats. Eur J Surg. 1997;163:297–304.PubMed Gertsch P, Stipa F, Ho J, Yuen ST, Luk I, Lauder IJ. Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats. Eur J Surg. 1997;163:297–304.PubMed
13.
go back to reference Doria C, Marino IR. Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report. Int Surg. 2003;88:184–187.PubMed Doria C, Marino IR. Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report. Int Surg. 2003;88:184–187.PubMed
14.
go back to reference Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2005;4:515–518.PubMed Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2005;4:515–518.PubMed
15.
go back to reference Ozkan U, Oguzkurt L, Tercan F, Tokmak N. Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis. Diagn Interv Radiol. 2006;12:105–107.PubMed Ozkan U, Oguzkurt L, Tercan F, Tokmak N. Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis. Diagn Interv Radiol. 2006;12:105–107.PubMed
20.
go back to reference Adani GL, Baccarani U, Risaliti A, Sponza M, Gasparini D, Bresadola F, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Intervent Radiol. 2007;30:1222–1226. Adani GL, Baccarani U, Risaliti A, Sponza M, Gasparini D, Bresadola F, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Intervent Radiol. 2007;30:1222–1226.
21.
go back to reference Karasu Z, Hulagu S, Gurakar A, et al. High incidence of noninfectious esophagitis in orthotopic liver transplant (olt) recipients. J Okla State Med Assoc. 2001;94:43–45.PubMed Karasu Z, Hulagu S, Gurakar A, et al. High incidence of noninfectious esophagitis in orthotopic liver transplant (olt) recipients. J Okla State Med Assoc. 2001;94:43–45.PubMed
22.
25.
go back to reference Shirota T, Kusano M, Kawamura O, Horikoshi T, Mori M, Sekiguchi T. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol. 1999;34:553–559. doi:10.1007/s005350050372.PubMedCrossRef Shirota T, Kusano M, Kawamura O, Horikoshi T, Mori M, Sekiguchi T. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol. 1999;34:553–559. doi:10.​1007/​s005350050372.PubMedCrossRef
27.
go back to reference Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am. 1995;9:1045–1074.PubMed Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am. 1995;9:1045–1074.PubMed
28.
go back to reference Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106:509–532.PubMed Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106:509–532.PubMed
29.
go back to reference Kaufman DB, Leventhal JR, Koffron A, et al. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. Surgery. 2000;128:726–737. doi:10.1067/msy.2000.108424.PubMedCrossRef Kaufman DB, Leventhal JR, Koffron A, et al. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. Surgery. 2000;128:726–737. doi:10.​1067/​msy.​2000.​108424.PubMedCrossRef
31.
go back to reference Barbaro G, Barbarini G, Di Lorenzo G. Fluconazole vs. itraconazole-flucytosine association in the treatment of esophageal candidiasis in aids patients. A double-blind, multicenter placebo-controlled study. The candida esophagitis multicenter italian study (cemis) group. Chest. 1996;110:1507–1514. doi:10.1378/chest.110.6.1507.PubMedCrossRef Barbaro G, Barbarini G, Di Lorenzo G. Fluconazole vs. itraconazole-flucytosine association in the treatment of esophageal candidiasis in aids patients. A double-blind, multicenter placebo-controlled study. The candida esophagitis multicenter italian study (cemis) group. Chest. 1996;110:1507–1514. doi:10.​1378/​chest.​110.​6.​1507.PubMedCrossRef
36.
go back to reference Gupta KL, Ghosh AK, Kochhar R, Jha V, Chakrabarti A, Sakhuja V. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol. 1994;89:1062–1065.PubMed Gupta KL, Ghosh AK, Kochhar R, Jha V, Chakrabarti A, Sakhuja V. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol. 1994;89:1062–1065.PubMed
38.
go back to reference Karchmer AW, Samore MH, Hadley S, Collins LA, Jenkins RL, Lewis WD. Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc. 1994;106:38–47. discussion 47–38. Karchmer AW, Samore MH, Hadley S, Collins LA, Jenkins RL, Lewis WD. Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc. 1994;106:38–47. discussion 47–38.
39.
go back to reference Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007;20:993–1015. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007;20:993–1015.
40.
go back to reference Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995;21:1077–1089. quiz 1090–1071. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995;21:1077–1089. quiz 1090–1071.
43.
go back to reference Dominguez EA. Long-term infectious complications of liver transplantation. Semin Liver Dis. 1995;15:133–138.PubMedCrossRef Dominguez EA. Long-term infectious complications of liver transplantation. Semin Liver Dis. 1995;15:133–138.PubMedCrossRef
44.
go back to reference Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with cmv disease. J Infect Dis. 2002;186:829–833. doi:10.1086/342601.PubMedCrossRef Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with cmv disease. J Infect Dis. 2002;186:829–833. doi:10.​1086/​342601.PubMedCrossRef
47.
go back to reference Gane E, Saliba F, Valdecasas GJ, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The oral ganciclovir international transplantation study group. Lancet. 1997;350:1729–1733. doi:10.1016/S0140-6736(97)05535-9.PubMedCrossRef Gane E, Saliba F, Valdecasas GJ, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The oral ganciclovir international transplantation study group. Lancet. 1997;350:1729–1733. doi:10.​1016/​S0140-6736(97)05535-9.PubMedCrossRef
49.
go back to reference Snydman DR. Counterpoint: prevention of cytomegalovirus (cmv) infection and cmv disease in recipients of solid organ transplants: the case for prophylaxis. Clin Infect Dis. 2005;40:709–712. doi:10.1086/427509.PubMedCrossRef Snydman DR. Counterpoint: prevention of cytomegalovirus (cmv) infection and cmv disease in recipients of solid organ transplants: the case for prophylaxis. Clin Infect Dis. 2005;40:709–712. doi:10.​1086/​427509.PubMedCrossRef
51.
go back to reference Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2005;CD003774. Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2005;CD003774.
52.
go back to reference Zamora MR, Nicolls MR, Hodges TN, et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of cmv infection following lung transplantation. Am J Transplant. 2004;4:1635–1642. doi:10.1111/j.1600-6143.2004.00571.x.PubMedCrossRef Zamora MR, Nicolls MR, Hodges TN, et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of cmv infection following lung transplantation. Am J Transplant. 2004;4:1635–1642. doi:10.​1111/​j.​1600-6143.​2004.​00571.​x.PubMedCrossRef
56.
60.
62.
go back to reference Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990;323:1767–1769.PubMed Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990;323:1767–1769.PubMed
63.
go back to reference Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant Sci. 1994;4:23–32.PubMed Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant Sci. 1994;4:23–32.PubMed
64.
67.
go back to reference Hassanein T, Gurakar A, Wright HI, Van Thiel DH. Major gastrointestinal bleeding occurring after liver transplantation. J Okla State Med Assoc. 1995;88:114–118.PubMed Hassanein T, Gurakar A, Wright HI, Van Thiel DH. Major gastrointestinal bleeding occurring after liver transplantation. J Okla State Med Assoc. 1995;88:114–118.PubMed
68.
go back to reference Wood RP, Shaw BWJ, Starzl TE. Extrahepatic complications of liver transplantation. Semin Liver Dis. 1985;5:377–384.PubMedCrossRef Wood RP, Shaw BWJ, Starzl TE. Extrahepatic complications of liver transplantation. Semin Liver Dis. 1985;5:377–384.PubMedCrossRef
70.
go back to reference Maaroos HI, Kekki M, Vorobjova T, Salupere V, Sipponen P. Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients. Scand J Gastroenterol. 1994;29:532–536. doi:10.3109/00365529409092468.PubMedCrossRef Maaroos HI, Kekki M, Vorobjova T, Salupere V, Sipponen P. Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients. Scand J Gastroenterol. 1994;29:532–536. doi:10.​3109/​0036552940909246​8.PubMedCrossRef
73.
go back to reference Starzl TE, Putnam CW, Hansbrough JF, Porter KA, Reid HA. Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery. 1977;81:212–221.PubMed Starzl TE, Putnam CW, Hansbrough JF, Porter KA, Reid HA. Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery. 1977;81:212–221.PubMed
77.
go back to reference Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc. 2002;55:224–231. doi:10.1067/mge.2002.120813.PubMedCrossRef Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc. 2002;55:224–231. doi:10.​1067/​mge.​2002.​120813.PubMedCrossRef
80.
go back to reference Hwang S, Lee SG, Sung KB, et al. Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl. 2006;12:831–838. doi:10.1002/lt.20693.PubMedCrossRef Hwang S, Lee SG, Sung KB, et al. Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl. 2006;12:831–838. doi:10.​1002/​lt.​20693.PubMedCrossRef
81.
go back to reference Yazumi S, Yoshimoto T, Hisatsune H, et al. Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg. 2006;13:502–510. doi:10.1007/s00534-005-1084-y.PubMedCrossRef Yazumi S, Yoshimoto T, Hisatsune H, et al. Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg. 2006;13:502–510. doi:10.​1007/​s00534-005-1084-y.PubMedCrossRef
82.
83.
go back to reference Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology. 1994;191:735–740.PubMed Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology. 1994;191:735–740.PubMed
84.
go back to reference Ostroff JW. Post-transplant biliary problems. Gastrointest Endosc Clin North Am. 2001;11:163–183. Ostroff JW. Post-transplant biliary problems. Gastrointest Endosc Clin North Am. 2001;11:163–183.
85.
go back to reference Moench C, Uhrig A, Lohse AW, Otto G. CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl. 2004;10:434–439. doi:10.1002/lt.20095.PubMedCrossRef Moench C, Uhrig A, Lohse AW, Otto G. CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl. 2004;10:434–439. doi:10.​1002/​lt.​20095.PubMedCrossRef
87.
88.
89.
92.
go back to reference Morelli J, Mulcahy HE, Willner IR, Cunningham JT, Draganov P. Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement. Gastrointest Endosc. 2003;58:374–379. doi:10.1067/S0016-5107(03)00011-7.PubMedCrossRef Morelli J, Mulcahy HE, Willner IR, Cunningham JT, Draganov P. Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement. Gastrointest Endosc. 2003;58:374–379. doi:10.​1067/​S0016-5107(03)00011-7.PubMedCrossRef
93.
go back to reference Wright H, Sharma S, Gurakar A, Sebastian A, Kohli V, Jabbour N. Management of biliary stricture guided by the Spyglass Direct Visualization System in a liver transplant recipient: an innovative approach. Gastrointest Endosc. 2008;67(7):1201–1203. doi:10.1016/j.gie.2007.10.055.PubMedCrossRef Wright H, Sharma S, Gurakar A, Sebastian A, Kohli V, Jabbour N. Management of biliary stricture guided by the Spyglass Direct Visualization System in a liver transplant recipient: an innovative approach. Gastrointest Endosc. 2008;67(7):1201–1203. doi:10.​1016/​j.​gie.​2007.​10.​055.PubMedCrossRef
94.
95.
go back to reference Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg. 2003;88:145–151.PubMed Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg. 2003;88:145–151.PubMed
102.
104.
go back to reference Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of epstein-barr virus-encoded small rna (by the eber-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med. 1992;327:1710–1714.PubMed Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of epstein-barr virus-encoded small rna (by the eber-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med. 1992;327:1710–1714.PubMed
105.
go back to reference Young L, Alfieri C, Hennessy K, et al. Expression of epstein-barr virus transformation-associated genes in tissues of patients with ebv lymphoproliferative disease. N Engl J Med. 1989;321:1080–1085.PubMed Young L, Alfieri C, Hennessy K, et al. Expression of epstein-barr virus transformation-associated genes in tissues of patients with ebv lymphoproliferative disease. N Engl J Med. 1989;321:1080–1085.PubMed
109.
go back to reference Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating epstein-barr virus (ebv)-infected lymphocytes and decreased ebv nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994;84:972–984.PubMed Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating epstein-barr virus (ebv)-infected lymphocytes and decreased ebv nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994;84:972–984.PubMed
110.
go back to reference Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive pcr to measure epstein-barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol. 1997;35:1612–1615.PubMed Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive pcr to measure epstein-barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol. 1997;35:1612–1615.PubMed
112.
113.
go back to reference Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429–436. discussion 436–427. doi:10.1097/00000658-200210000-00005 Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429–436. discussion 436–427. doi:10.​1097/​00000658-200210000-00005
116.
go back to reference Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Posttransplantation lymphoproliferative disorder––the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of epstein-barr virus. Liver Transpl. 2007;13:904–912. doi:10.1002/lt.21152.PubMedCrossRef Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Posttransplantation lymphoproliferative disorder––the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of epstein-barr virus. Liver Transpl. 2007;13:904–912. doi:10.​1002/​lt.​21152.PubMedCrossRef
119.
go back to reference Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995;20:1346–1353.PubMed Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995;20:1346–1353.PubMed
121.
go back to reference Zangwill SD, Hsu DT, Kichuk MR, et al. Incidence and outcome of primary epstein-barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant. 1998;17:1161–1166.PubMed Zangwill SD, Hsu DT, Kichuk MR, et al. Incidence and outcome of primary epstein-barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant. 1998;17:1161–1166.PubMed
122.
go back to reference Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine a-prednisone immunosuppression. Am J Pathol. 1988;133:173–192.PubMed Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine a-prednisone immunosuppression. Am J Pathol. 1988;133:173–192.PubMed
124.
go back to reference Younes BS, Ament ME, McDiarmid SV, Martin MG, Vargas JH. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 1999;28:380–385. doi:10.1097/00005176-199904000-00007.PubMedCrossRef Younes BS, Ament ME, McDiarmid SV, Martin MG, Vargas JH. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 1999;28:380–385. doi:10.​1097/​00005176-199904000-00007.PubMedCrossRef
128.
go back to reference Tsai DE, Hardy CL, Tomaszewski JE, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation. 2001;71:1076–1088. doi:10.1097/00007890-200104270-00012.PubMedCrossRef Tsai DE, Hardy CL, Tomaszewski JE, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation. 2001;71:1076–1088. doi:10.​1097/​00007890-200104270-00012.PubMedCrossRef
129.
go back to reference Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991;10:877–886. discussion 886–877. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991;10:877–886. discussion 886–877.
130.
go back to reference Oertel S, Trappe RU, Zeidler K, et al. Epstein-barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol. 2006;85:478–484. doi:10.1007/s00277-006-0109-1.PubMedCrossRef Oertel S, Trappe RU, Zeidler K, et al. Epstein-barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol. 2006;85:478–484. doi:10.​1007/​s00277-006-0109-1.PubMedCrossRef
131.
go back to reference Yang J, Tao Q, Flinn IW, et al. Characterization of epstein-barr virus-infected b cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood. 2000;96:4055–4063.PubMed Yang J, Tao Q, Flinn IW, et al. Characterization of epstein-barr virus-infected b cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood. 2000;96:4055–4063.PubMed
133.
go back to reference Green M, Cacciarelli TV, Mazariegos GV, et al. Serial measurement of epstein-barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998;66:1641–1644. doi:10.1097/00007890-199812270-00012.PubMedCrossRef Green M, Cacciarelli TV, Mazariegos GV, et al. Serial measurement of epstein-barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998;66:1641–1644. doi:10.​1097/​00007890-199812270-00012.PubMedCrossRef
134.
go back to reference Trofe J, Buell JF, Beebe TM, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the israel penn international transplant tumor registry experience. Am J Transplant. 2005;5:775–780. doi:10.1111/j.1600-6143.2005.00776.x.PubMedCrossRef Trofe J, Buell JF, Beebe TM, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the israel penn international transplant tumor registry experience. Am J Transplant. 2005;5:775–780. doi:10.​1111/​j.​1600-6143.​2005.​00776.​x.PubMedCrossRef
135.
136.
go back to reference Stevens SJ, Verschuuren EA, Pronk I, et al. Frequent monitoring of epstein-barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. 2001;97:1165–1171. doi:10.1182/blood.V97.5.1165.PubMedCrossRef Stevens SJ, Verschuuren EA, Pronk I, et al. Frequent monitoring of epstein-barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. 2001;97:1165–1171. doi:10.​1182/​blood.​V97.​5.​1165.PubMedCrossRef
138.
go back to reference Bodova I, Horakova J, Lukac J, Cupanikova D, Plank L. Autoimmune hemolytic anemia and chronic giant cell hepatitis. Bratisl Lek Listy (Tlacene Vyd). 2000;101:54–56. Bodova I, Horakova J, Lukac J, Cupanikova D, Plank L. Autoimmune hemolytic anemia and chronic giant cell hepatitis. Bratisl Lek Listy (Tlacene Vyd). 2000;101:54–56.
141.
go back to reference Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against hhv-8. Medicine (Baltimore). 2002;81:293–304. doi:10.1097/00005792-200207000-00005.CrossRef Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against hhv-8. Medicine (Baltimore). 2002;81:293–304. doi:10.​1097/​00005792-200207000-00005.CrossRef
145.
go back to reference Lin CH, Hsu CW, Chiang YJ, Ng KF, Chiu CT. Esophageal and gastric kaposi’s sarcomas presenting as upper gastrointestinal bleeding. Chang Gung Med J. 2002;25:329–333.PubMed Lin CH, Hsu CW, Chiang YJ, Ng KF, Chiu CT. Esophageal and gastric kaposi’s sarcomas presenting as upper gastrointestinal bleeding. Chang Gung Med J. 2002;25:329–333.PubMed
146.
go back to reference Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal malignancy in patients with aids. Am J Gastroenterol. 1991;86:715–718.PubMed Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal malignancy in patients with aids. Am J Gastroenterol. 1991;86:715–718.PubMed
147.
go back to reference Friedman SL, Wright TL, Altman DF. Gastrointestinal kaposi’s sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology. 1985;89:102–108.PubMed Friedman SL, Wright TL, Altman DF. Gastrointestinal kaposi’s sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology. 1985;89:102–108.PubMed
148.
go back to reference Ioachim HL, Adsay V, Giancotti FR, Dorsett B, Melamed J. Kaposi’s sarcoma of internal organs. A multiparameter study of 86 cases. Cancer. 1995;75:1376–1385. doi :10.1002/1097-0142(19950315)75:6<1376::AID-CNCR2820750621>3.0.CO;2-Y.PubMedCrossRef Ioachim HL, Adsay V, Giancotti FR, Dorsett B, Melamed J. Kaposi’s sarcoma of internal organs. A multiparameter study of 86 cases. Cancer. 1995;75:1376–1385. doi :10.1002/1097-0142(19950315)75:6<1376::AID-CNCR2820750621>3.0.CO;2-Y.PubMedCrossRef
153.
go back to reference Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis. 1996;22:537–549.PubMed Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis. 1996;22:537–549.PubMed
158.
go back to reference Riley TR, Schoen RE, Lee RG, Rakela J. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol. 1997;92:279–282.PubMed Riley TR, Schoen RE, Lee RG, Rakela J. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol. 1997;92:279–282.PubMed
159.
go back to reference Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology. 1983;85:713–717.PubMed Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology. 1983;85:713–717.PubMed
161.
go back to reference Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut. 1998;43:639–644.PubMedCrossRef Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut. 1998;43:639–644.PubMedCrossRef
169.
go back to reference Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997;40:451–456. doi:10.1007/BF02258391.PubMedCrossRef Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997;40:451–456. doi:10.​1007/​BF02258391.PubMedCrossRef
174.
go back to reference Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with hla-dr beta chain: a means for graft rejection and immunosuppression. J Virol. 1988;62:100–105.PubMed Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with hla-dr beta chain: a means for graft rejection and immunosuppression. J Virol. 1988;62:100–105.PubMed
176.
177.
go back to reference Crowley B, Dempsey J, Olujohungbe A, Khan A, Mutton K, Hart CA. Unusual manifestations of primary cytomegalovirus infection in patients without hiv infection and without organ transplants. J Med Virol. 2002;68:237–240. doi:10.1002/jmv.10200.PubMedCrossRef Crowley B, Dempsey J, Olujohungbe A, Khan A, Mutton K, Hart CA. Unusual manifestations of primary cytomegalovirus infection in patients without hiv infection and without organ transplants. J Med Virol. 2002;68:237–240. doi:10.​1002/​jmv.​10200.PubMedCrossRef
178.
go back to reference Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155–1160. doi:10.1099/jmm.0.45629-0.PubMedCrossRef Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155–1160. doi:10.​1099/​jmm.​0.​45629-0.PubMedCrossRef
179.
180.
go back to reference Loftus EVJ, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998;27:685–690. doi:10.1002/hep.510270308.PubMedCrossRef Loftus EVJ, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998;27:685–690. doi:10.​1002/​hep.​510270308.PubMedCrossRef
184.
go back to reference Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis. 1990;12(Suppl 2):S243–S251.PubMed Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis. 1990;12(Suppl 2):S243–S251.PubMed
186.
go back to reference Willingham FF, Ticona Chavez E, Taylor DN, et al. Diarrhea andClostridium difficile infection in latin American patients with aids. Working group on aids in Peru. Clin Infect Dis. 1998;27:487–493. doi:10.1086/514688.PubMedCrossRef Willingham FF, Ticona Chavez E, Taylor DN, et al. Diarrhea andClostridium difficile infection in latin American patients with aids. Working group on aids in Peru. Clin Infect Dis. 1998;27:487–493. doi:10.​1086/​514688.PubMedCrossRef
187.
go back to reference Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–280. doi:10.1086/502539.PubMedCrossRef Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–280. doi:10.​1086/​502539.PubMedCrossRef
188.
go back to reference Hashimoto M, Sugawara Y, Tamura S, et al. Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol. 2007;13:2072–2076.PubMed Hashimoto M, Sugawara Y, Tamura S, et al. Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol. 2007;13:2072–2076.PubMed
189.
go back to reference Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23:653–659. doi:10.1086/501989.PubMedCrossRef Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23:653–659. doi:10.​1086/​501989.PubMedCrossRef
191.
go back to reference Wanahita A, Goldsmith EA, Musher DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34:1585–1592. doi:10.1086/340536.PubMedCrossRef Wanahita A, Goldsmith EA, Musher DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34:1585–1592. doi:10.​1086/​340536.PubMedCrossRef
192.
go back to reference Seppala K, Hjelt L, Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. Scand J Gastroenterol. 1981;16:465–468.PubMedCrossRef Seppala K, Hjelt L, Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. Scand J Gastroenterol. 1981;16:465–468.PubMedCrossRef
194.
go back to reference Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva JJ. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16:459–477.PubMedCrossRef Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva JJ. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16:459–477.PubMedCrossRef
195.
go back to reference George WL, Rolfe RD, Finegold SM. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol. 1982;15:1049–1053.PubMed George WL, Rolfe RD, Finegold SM. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol. 1982;15:1049–1053.PubMed
197.
go back to reference Tedesco FJ. Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology. 1979;77:295–297.PubMed Tedesco FJ. Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology. 1979;77:295–297.PubMed
205.
go back to reference Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way hla matching. Liver Transpl. 2006;12:140–145. doi:10.1002/lt.20573.PubMedCrossRef Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way hla matching. Liver Transpl. 2006;12:140–145. doi:10.​1002/​lt.​20573.PubMedCrossRef
206.
go back to reference Matthes-Martin S, Aberle SW, Peters C, et al. Cmv-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. Bone Marrow Transplant. 1998;21(Suppl 2):S53–S56.PubMed Matthes-Martin S, Aberle SW, Peters C, et al. Cmv-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. Bone Marrow Transplant. 1998;21(Suppl 2):S53–S56.PubMed
211.
go back to reference Whitington PF, Rubin CM, Alonso EM, et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation. 1996;62:1516–1519. doi:10.1097/00007890-199611270-00025.PubMedCrossRef Whitington PF, Rubin CM, Alonso EM, et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation. 1996;62:1516–1519. doi:10.​1097/​00007890-199611270-00025.PubMedCrossRef
214.
go back to reference Bombi JA, Nadal A, Carreras E, et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol. 1995;103:690–695.PubMed Bombi JA, Nadal A, Carreras E, et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol. 1995;103:690–695.PubMed
Metadata
Title
Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part II
Authors
Sharad Sharma
Ahmet Gurakar
Cemalettin Camci
Nicolas Jabbour
Publication date
01-07-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0520-7

Other articles of this Issue 7/2009

Digestive Diseases and Sciences 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.